RESUMO
OBJECTIVE: Erectile dysfunction (ED), defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance, is the most common sexual problem in men. ED arises when there is disruption of the complex interplay between vascular, neurologic, hormonal and psychologic factors necessary for normal erectile function. It may have a significant effect on quality of life and portend undetected cardiovascular disease. Risk factors for development of ED include advancing age, tobacco use, a history of pelvic irradiation or surgery and antipsychotic use (Table 1) [1]. Treatment guidelines continue to evolve for optimal management of ED. In this article, we review diagnostic and treatment strategies for ED relevant to psychiatrists. METHOD: We present an integrative approach to the treatment of ED based on a review of the urologic and psychiatric literature. RESULTS: ED is multifactorial in origin and responsive to a variety of therapeutic interventions, including psychopharmacology and psychotherapy in which cognitive underpinnings of poor sexual performance, including diminished self-esteem, lack of confidence and perceived failures in the male role, are examined. CONCLUSIONS: Psychiatrists can readily perform a basic workup for ED as they integrate both a medical and therapeutic model when confronted with such patients.
Assuntos
Antidepressivos/uso terapêutico , Disfunção Erétil/terapia , Inibidores da Fosfodiesterase 5/uso terapêutico , Psicoterapia/métodos , Disfunções Sexuais Psicogênicas/terapia , Terapia Combinada/métodos , Depressão/psicologia , Disfunção Erétil/diagnóstico , Disfunção Erétil/psicologia , Humanos , Masculino , Esquizofrenia , Psicologia do Esquizofrênico , Disfunções Sexuais Psicogênicas/psicologiaAssuntos
Demência/complicações , Disfunção Erétil/complicações , Pênis/lesões , Automutilação/diagnóstico , Transexualidade/psicologia , Adulto , Atitude do Pessoal de Saúde , Modificação Corporal não Terapêutica , Contratransferência , Demência/patologia , Transtorno Depressivo/complicações , Transtorno Depressivo/patologia , Fasciite Necrosante/cirurgia , Gangrena , Hemorragia/etiologia , Hemorragia/cirurgia , Humanos , Hidrocefalia/complicações , Hidrocefalia/diagnóstico por imagem , Ligadura/efeitos adversos , Masculino , Pessoa de Meia-Idade , Orquiectomia/efeitos adversos , Orquiectomia/psicologia , Prótese de Pênis , Pênis/patologia , Pênis/cirurgia , Radiografia , Encaminhamento e Consulta , Escroto/lesões , Escroto/cirurgia , Automutilação/etiologia , Automutilação/psicologia , Automutilação/cirurgia , Transexualidade/terapiaRESUMO
INTRODUCTION: The out-of-pocket cost for an elective orchiectomy, which is often not covered by health insurance, is a significant barrier to male-to-female transsexuals ready to proceed with their physical transition. This and other barriers (lack of access to a surgeon willing to perform the operation, waiting times, and underlying psychological and psychiatric conditions) lead a subset of transsexual women to attempt self-castration. Little information has been published on the financial costs and implications of self-castration to both patients and health care systems. AIM: We compare the financial and psychological costs of elective surgical orchiectomy vs. self-castration in the case of a transsexual woman in her 40s. METHODS: We interviewed the patient and her providers and obtained financial information from local reimbursement and billing specialists. RESULTS: After experiencing minor hemorrhage following the self-castration, our patient presented to the emergency department and underwent a bilateral inguinal exploration, ligation and removal of bilateral spermatic cords, and complicated scrotal exploration, debridement, and closure. She was admitted to the psychiatric service for a hospital stay of three days. The total bill was U.S. $14,923, which would compare with U.S. $4,000 for an elective outpatient orchiectomy in the patient's geographical area. CONCLUSIONS: From a financial standpoint, an elective orchiectomy could have cost the health care system significantly less than a hospital admission with its associated additional costs. From a patient safety standpoint, elective orchiectomy is preferable to self-castration which carries significant risks such as hemorrhage, disfigurement, infection, urinary fistulae, and nerve damage. Healthcare providers of transsexual women should carefully explore patient attitudes toward self-castration and work toward improving access to elective orchiectomy to reduce the number of self-castrations and costs to the overall health care system. Further research on the financial implications of self-castration from different health care systems and from a series of patients is needed.